Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells

Nature Genetics volume 39, pages 391–396 (2007)Cite this article

Abstract

Studies have shown that DNA (cytosine-5-)-methyltransferase 1 (DNMT1) is the principal enzyme responsible for maintaining CpG methylation and is required for embryonic development and survival of somatic cells in mice1,2,3. The role of DNMT1 in human cancer cells, however, remains highly controversial4,5,6,7. Using homologous recombination, here we have generated a DNMT1 conditional allele in the human colorectal carcinoma cell line HCT116 in which several exons encoding the catalytic domain are flanked by loxP sites. Cre recombinase–mediated disruption of this allele results in hemimethylation of ∼20% of CpG-CpG dyads in the genome, coupled with activation of the G2/M checkpoint, leading to arrest in the G2 phase of the cell cycle. Although cells gradually escape from this arrest, they show severe mitotic defects and undergo cell death either during mitosis or after arresting in a tetraploid G1 state. Our results thus show that DNMT1 is required for faithfully maintaining DNA methylation patterns in human cancer cells and is essential for their proliferation and survival.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Targeted disruption of DNMT1 in HCT116 cells.
Figure 2: Inactivation of DNMT1 in HCT116 cells results in cell-cycle arrest and cell death.
Figure 3: DNMT1 mutant cells undergo mitotic catastrophe.
Figure 4: The G2/M checkpoint is activated in DNMT1 mutant cells.
Figure 5: DNMT1 mutant cells show hemimethylation of CpG sites.
Figure 6: Model of the effects of DNMT1 loss on the proliferation and survival of human cancer cells.

Similar content being viewed by others

References

  1. Li, E., Bestor, T.H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926 (1992).

    Article  CAS  Google Scholar 

  2. Lei, H. et al. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122, 3195–3205 (1996).

    CAS  PubMed  Google Scholar 

  3. Jackson-Grusby, L. et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat. Genet. 27, 31–39 (2001).

    Article  CAS  Google Scholar 

  4. Rhee, I. et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552–556 (2002).

    Article  CAS  Google Scholar 

  5. Rhee, I. et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404, 1003–1007 (2000).

    Article  CAS  Google Scholar 

  6. Robert, M.F. et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet. 33, 61–65 (2003).

    Article  CAS  Google Scholar 

  7. Ting, A.H. et al. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Nat. Genet. 36, 582–584 (2004).

    Article  CAS  Google Scholar 

  8. Feil, R., Wagner, J., Metzger, D. & Chambon, P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun. 237, 752–757 (1997).

    Article  CAS  Google Scholar 

  9. Kanda, T., Sullivan, K.F. & Wahl, G.M. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 8, 377–385 (1998).

    Article  CAS  Google Scholar 

  10. Castedo, M. et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825–2837 (2004).

    Article  CAS  Google Scholar 

  11. Fenech, M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov. Today 7, 1128–1137 (2002).

    Article  CAS  Google Scholar 

  12. Canman, C.E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677–1679 (1998).

    Article  CAS  Google Scholar 

  13. Siliciano, J.D. et al. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11, 3471–3481 (1997).

    Article  CAS  Google Scholar 

  14. Minn, A.J., Boise, L.H. & Thompson, C.B. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10, 2621–2631 (1996).

    Article  CAS  Google Scholar 

  15. Lanni, J.S. & Jacks, T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18, 1055–1064 (1998).

    Article  CAS  Google Scholar 

  16. Andreassen, P.R., Lohez, O.D., Lacroix, F.B. & Margolis, R.L. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell 12, 1315–1328 (2001).

    Article  CAS  Google Scholar 

  17. Laird, C.D. et al. Hairpin-bisulfite PCR: assessing epigenetic methylation patterns on complementary strands of individual DNA molecules. Proc. Natl. Acad. Sci. USA 101, 204–209 (2004).

    Article  CAS  Google Scholar 

  18. Egger, G. et al. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc. Natl. Acad. Sci. USA 103, 14080–14085 (2006).

    Article  CAS  Google Scholar 

  19. Chen, T., Ueda, Y., Dodge, J.E., Wang, Z. & Li, E. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23, 5594–5605 (2003).

    Article  CAS  Google Scholar 

  20. Ueda, Y. et al. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development 133, 1183–1192 (2006).

    Article  CAS  Google Scholar 

  21. Chen, T., Ueda, Y., Xie, S. & Li, E. A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J. Biol. Chem. 277, 38746–38754 (2002).

    Article  CAS  Google Scholar 

  22. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821–9826 (1996).

    Article  CAS  Google Scholar 

  23. Crain, P.F. Preparation and enzymatic hydrolysis of DNA and RNA for mass spectrometry. Methods Enzymol. 193, 782–790 (1990).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank colleagues at Novartis Institutes for Biomedical Research, particularly Y. Kurash, C. Timmers, F. Gaudet, S. Kadam, K. Wang and Y.-N.P. Chen for discussions; W. Marston, A. Ho and A. Szilvasi for technical assistance with flow cytometric analyses; and Y. Liu for statistical analysis. We also thank T. Kanda, G. Wahl and H. Kimura for the human H2B-GFP plasmid; and P. Chambon for the Cre-ERT2 plasmid.

Author information

Author notes

  1. Yoshihide Ueda

    Present address: Present address: Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.,

Authors and Affiliations

  1. Epigenetics Program, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, 02139, Massachusetts, USA

    Taiping Chen, Sarah Hevi, Frédérique Gay, Naomi Tsujimoto & En Li

  2. Central Technologies, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, 02139, Massachusetts, USA

    Timothy He & Bailin Zhang

  3. Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, 02129, Massachusetts, USA

    Yoshihide Ueda

Authors
  1. Taiping Chen
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Sarah Hevi
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Frédérique Gay
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Naomi Tsujimoto
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Timothy He
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Bailin Zhang
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Yoshihide Ueda
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. En Li
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

T.C. designed the experiments, performed DNA methylation analyses, and wrote the paper; S.H., F.G. and N.T. carried out most of the experiments; F.G. also helped to write the paper; T.H. and B.Z. measured the 5-methylcytosine content by LC-MS/MS; Y.U. generated the targeting vectors; and E.L. conceived the study.

Corresponding author

Correspondence to En Li.

Ethics declarations

Competing interests

All authors except Y.U. are employees of Novartis Institutes for Biomedical Research.

Supplementary information

Supplementary Fig. 1

DNMT1 mutant cells lack DNMT1 protein products. (PDF 117 kb)

Supplementary Fig. 2

Loss of DNMT1 impairs cell cycle progression. (PDF 19 kb)

Supplementary Fig. 3

DNMT1 mutant cells display nuclear abnormalities. (PDF 16 kb)

Supplementary Fig. 4

Loss of DNMT1 induces chromosome instability. (PDF 147 kb)

Supplementary Table 1

Oligonucleotides used in this study. (PDF 25 kb)

Supplementary Video 1

Mitosis of wild-type HCT116 cells. HCT116 cells stably expressing H2B-GFP were cultured in the presence of 4-HT for 24 h and then visualized and photographed at 6-min intervals for another 24 h. The video, which was generated by combining the first 100 images, shows the normal progression of mitosis (1 s corresponds to 30 min of real time). (MOV 746 kb)

Supplementary Video 2

Mitotic catastrophe in DNMT1 mutant HCT116 cells. DNMT12loxP/KO (#201) cells stably expressing H2B-GFP were cultured in the presence of 4-HT for 24 h and then visualized and photographed at 6-min intervals for another 24 h. The video, which was generated by combining the first 175 images, shows various defects characteristic of mitotic catastrophe, including broken chromosomes, chromosome misalignment/missegregation, cell death during mitosis, formation of a binucleated cell, and apoptosis of a multinucleated cell (1 s corresponds to 30 min of real time). Note that many cells did not enter mitosis within the course of visualization, consistent with G2 arrest. (MOV 1345 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, T., Hevi, S., Gay, F. et al. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat Genet 39, 391–396 (2007). https://doi.org/10.1038/ng1982

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1982

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing